colon cancer therapy (NCI)

Pooled mutant-KRAS peptide vaccine (Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

mRNA vaccine targeting KRAS mutant antigens (cancer)

siRNA agent (colon cancer)

Mutant KRAS Inhibitors (solid tumor)

Mutant KRAS G12V-specific TCR tranduced autologous T cell therapy (Changhai Hospital of Shanghai)

SOS1 / KRAS (KRAS -driven cancer)

KRAS-mutant Tumor(Ionova Life Science)

Sotorasib(Lumakras, Lumykras)

C₃₀H₃₀F₂N₆O₃

multi-KRAS inhibitor (cancer)